Latest Developments in Global Plasma Therapy Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Plasma Therapy Market

  • Healthcare
  • Upcoming Report
  • Jan 2025
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

  • In October 2021, BioLife Plasma Services (U.S.) launched a new plasma center in Worcester, to address the rising demand for plasma-based therapies
  • In August 2021, Biotest AG (Germany) opened its sixth plasma collection center in the Czech Republic, ensuring a long-term supply of plasma for therapeutic needs
  • In July 2020, Grifols, a prominent producer of plasma-derived medicines, signed an agreement with GC Pharma to acquire a plasma fractionation facility in Montreal, along with 11 U.S.-based plasma collection centers and two purification facilities, strengthening its market position and revenue
  • In June 2020, CSL Behring (Australia) reached an agreement to acquire Vitaeris Inc., a clinical-stage biotechnology company, to advance the Phase III development of canakinumab, an anti-interleukin-6 (IL-6) monoclonal antibody (MAB)
  • In March 2020, Takeda Pharmaceutical Company Limited initiated the development of anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG)-TAK-888 for COVID-19 treatment, accelerating therapeutic advancements for effective disease management

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Pure PRP, Leucocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin), Source (Autologous and Allogenic), Application (Orthopedics, Dermatology, Dental, Cardiac Muscle Injury, Nerve Injury, and Others), End User (Hospitals and Clinics and Research Institutions) – Industry Trends and Forecast to 2032 .
The Global Plasma Therapy Market size was valued at USD 436.97 USD Million in 2024.
The Global Plasma Therapy Market is projected to grow at a CAGR of 13.66% during the forecast period of 2025 to 2032.
The major players operating in the market include Arthrex , Bio Products Laboratory , Takeda Pharmaceutical Company Limited, Biotest AG, and others .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.